SAC Capital adds to position in ARIAD Pharmaceuticals (ARIA)

Posted on April 27th, 2012 by whalewisdom

SAC Capital has just put out a new Schedule 13G disclosing ownership in 7,876,700 shares of ARIA as of April 17th.  This gives SAC 4.9% ownership in ARIA and is an increase of 5,325,375 shares over their last reported position on 12/31/2011.

ARIAD Pharmaceutials is an oncology company focusing on the discovery, development, and commercialization of medicines for cancer patients.

SAC Capital is a Connecticut based hedge fund found by Steven Cohen in 1992.

 

Ownership History in ARIA
Reported via Date Name Ticker Shares % of Portfolio
13F 2009-12-31 Ariad Pharmaceuticals Inc. ARIA 76,892 0.00
13F 2010-09-30 Ariad Pharmaceuticals Inc. ARIA 600 0.00
13F 2011-03-31 Ariad Pharmaceuticals Inc. ARIA 18,285 0.00
13F 2011-06-30 Ariad Pharmaceuticals Inc. ARIA 109,578 0.01
13F 2011-09-30 Ariad Pharmaceuticals Inc. ARIA 176,796 0.01
13F 2011-12-31 Ariad Pharmaceuticals Inc. ARIA 2,551,325 0.20
SC 13G 2012-04-27 Ariad Pharmaceuticals Inc. ARIA 7,876,700 N/A

This entry was posted on Friday, April 27th, 2012 at 4:33 pm and is filed under 13D/G. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.